VJOncology Podcast

The Video Journal of Oncology (VJOncology) podcast covers the latest solid oncology news from international experts, including breast, lung, skin, genitourinary, head and neck, gynecological and more!Made for healthcare professionals and researchers, we are a global, independent, open-access platform. Listen to the latest news, including cutting-edge trial updates, controversies and opinion.If you enjoy the podcast, please leave us a rating and review! For more news visit www.vjoncology.com

VJOncology Podcast is a health podcast hosted by VJOncology, with 233 episodes on record and a Required Pod Score of 80.

VJOncology hosts VJOncology Podcast, a health show with 233 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #243

  Lung cancer highlights from WCLC 2026

  Sep 18, 202619 min

  In this week’s VJOncology podcast, we had the opportunity to attend the 2026 World Conference on Lung Cancer (WCLC) in Seoul, South Korea, where we explored the latest advances across thoracic oncology. Join Tom Newsom-Davis of Chelsea and Westminster Hospital NHS Foundation Trust, London, UK, Giulia Pasello of Institute Oncology Veneto, Padua, Italy, Alexander Spira of Virginia Cancer Specialists and US Oncology, Fairfax, VA, Mark Jeng of Memorial Sloan Kettering Cancer Center, New York, NY, and Triparna Sen, Ohio State University, Columbus, OH, as they discuss the PAPILLON and REZILIENT 3 studies, perioperative treatment in mesothelioma, advances in small cell lung cancer, and more.

  ListenShow Notes
• 

  Episode #242

  New frontiers in brain tumor treatment: from immunotherapy to precision medicine

  Sep 11, 202617 min

  In this week’s VJOncology podcast, we explore the latest developments in neuro-oncology, including emerging approaches in immunotherapy, PARP inhibition, and radioligand therapy. Join Nicholas Blondin and Sylvia Kurz of Yale University School of Medicine, New Haven, CT, Martin Hojgaard of Rigshospitalet, Copenhagen, Denmark, Tolga Tuncer of the University of Kansas Medical Center, Kansas, KC, and Dinu Stefan of François Baclese Cancer Center, Caen, France, as they discuss key ASCO findings, including the MAGMA and ROADS trials, lutetium-177 dotatate in meningioma, the molecular landscape of MTAP deletions, neoantigen-specific T-cell therapy for glioblastoma, and intermittent olaparib combined with radiotherapy and temozolomide in high-grade gliomas.

  ListenShow Notes
• 

  Episode #241

  Gynecologic cancer awareness month: recent advances in treatment and diagnosis

  Sep 4, 202619 min

  In recognition of Gynecologic Cancer Awareness Month, this episode of VJOncology podcasts explores recent advances shaping the treatment and diagnosis of gynecologic cancer. Join leading experts Linda Mileshkin of Peter MacCallum Cancer Center, Melbourne, Australia, Martin Hojgaard of Rigshospitalet, Copenhagen, Denmark, Claudia Marchetti of Fondazione Policlinico Universitario Agostino Gemelli IRCSS, Rome, Italy, and Shailendra Dandge of the Society for Health Allied Research Education India, Hyderabad, India, as they discuss key developments. They cover new data for novel therapeutics including puxitatug samrotecan and EIK1003, the prognostic effect of neoadjuvant chemotherapy in ovarian cancer and a community health volunteer-led intervention to improve cervical cancer screening participation in low-resource settings.

  ListenShow Notes
• 

  Episode #240

  Beyond lutetium: the next wave of radiopharmaceuticals in prostate cancer

  Aug 28, 202618 min

  In this week’s VJOncology podcast, we explore recent advances in therapeutic radiopharmaceuticals for metastatic castration-resistant prostate cancer, including emerging alternatives to lutetium-177. Join Jeremie Calais of University of California, Los Angeles, CA, Pedro Barata of Seidman Cancer Center, Cleveland, OH, and Enrique Gallardo of Parc Taulí University Hospital, Barcelona, Spain, as they discuss actinium-225-based PSMA-targeted radioligand therapies, findings from the CONVERGE-01, AcTION, and ProstACT Global trials, the expanding PSMA-targeted treatment landscape, and final overall survival results from PEACE-3.

  ListenShow Notes
• 

  Episode #239

  Immunotherapy updates in head and neck cancer from ASCO 2026

  Aug 14, 202619 min

  On this week’s episode of VJOncology podcasts, we bring you head and neck cancer highlights in immuno-oncology from the 2026 ASCO Annual Conference. Join Barbara Burtness from the Yale School of Medicine, Hannah Kenny from Thomas Jefferson University Hospital, Ari Rosenberg from the University of Chicago, Nabil Saba from Emory University, and Kedar Kirtane from Moffitt Cancer Center as they discuss highlights from the meeting. They explore new data from key trials including OrigAMI-4, EV-202 and KEYNOTE-412, as well as emerging cellular therapies and checkpoint inhibitors.

  ListenShow Notes

Recent guests on VJOncology Podcast. Study who booked and why before you pitch.

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.